|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- October 28, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Alnylam Pharmaceuticals Inc., of Cambridge, Mass., and Koken Co. Ltd., of Tokyo, said Alnylam has granted Koken a nonexclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family. The patent family covers fundamental aspects of the structure and uses of RNAi products, including small interfering RNAs and their use to mediate RNAi in mammalian cells, and of RNAi-related mechanisms. Financial details were not disclosed.
o Champions Biotechnology Inc., of Baltimore, established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd. for the development and commercialization of ...